• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.
    All News #Library

    Sato’s Receives FDA Warning Letter

    FDA

    GC America’s Receives FDA Warning Letter

    FDA

    Alchymars ICM SM’s Receives FDA Warning Letter

    FDA

    Enforcement Report - Week of May 20, 2026

    FDA

    JW Nutritional’s Receives FDA Warning Letter

    FDA

    Sourav K Mishra’s Receives FDA Warning Letter

    FDA

    Naseem A Jaffrani’s Receives FDA Warning Letter

    FDA

    Hangzhou Yiqi Biotechnology’s Receives FDA Warning Letter

    FDA

    Alchymars ICM SM Private Limited is on FDA Import Alert List

    FDA

    Best Supplements Recalls WAP Capsules for Undeclared Active Drugs

    FDA

    Umami Is on FDA Import Alert List

    FDA

    Vitalis Industria De Alimentos Ltda Is on FDA Import Alert List

    FDA

    Sun Pharma Recalls Doxorubicin Injection Over Glass Particle Risk

    FDA

    Enforcement Report - Week of May 13, 2026

    FDA

    ProRx’s Receives FDA Warning Letter

    FDA

    IDO Pharma’s Receives FDA Warning Letter

    FDA

    Mukesh B Chandre’s Receives FDA Warning Letter

    FDA

    Pharmacal Issues Nationwide Recall of MG217 Eczema Cream

    FDA

    Navesta Pharma Fails EDQM Inspection

    EMA

    Enforcement Report - Week of May 6, 2026

    FDA

    Ava’s Receives FDA Warning Letter

    FDA

    CareFusion 213’s Receives FDA Warning Letter

    FDA

    Respilon Production S R O’s Receives FDA Warning Letter

    FDA

    Active Cosmetics Manufacturing’s Receives FDA Warning Letter

    FDA

    Zenzi Pharmaceutical Fails EDQM Inspection

    EMA

    Shaanxi Lifecare Biotech is on FDA Import Alert List

    FDA

    B. Braun Issues Voluntary Recall of Lactated Ringer’s Injection

    FDA

    Lexia’s Receives FDA Warning Letter

    FDA

    Intas’ Receives FDA Warning Letter

    FDA

    Pharmathen International is on FDA Import Alert List

    FDA

    Laboratorios Jaloma S.A. de C.V. is on FDA Import Alert List

    FDA

    Enforcement Report - Week of April 22, 2026

    FDA

    Par Health’s Receives FDA Warning Letter

    FDA

    RC Outsourcing’s Receives FDA Warning Letter

    FDA

    UCSF Radiopharmaceutical Facility’s Receives FDA Warning Letter

    FDA

    Apollo Care’s Receives FDA Warning Letter

    FDA

    Xiamen Kang Zhongyuan Biotechnology’s Receives FDA Warning Letter

    FDA

    Thrive Health and Wellness’ Receives FDA Warning Letter

    FDA

    Produlab Pharma Production Fails EDQM Inspection

    EMA

    Veyx-Pharma B.V. Production Fails EDQM Inspection

    EMA

    Cabio Biotech Wuhan is on FDA Import Alert List

    FDA

    Jiangmen Shuizirun Sanitary Articles is on FDA Import Alert List

    FDA

    Swiss Parenterals Limited Production Fails EDQM Inspection

    EMA

    Enforcement Report - Week of April 15, 2026

    FDA

    Peyrano Torino Is on FDA Import Alert List

    FDA

    Gomar Pinczow Sp. z o.o. SKA Is on FDA Import Alert List

    FDA

    Fffood Sp. Z.o.o. Is on FDA Import Alert List

    FDA

    Rafael Dybvik Is on FDA Import Alert List

    FDA

    FDA Issues Form 483 to Wells Pharmacy

    FDA

    Pure Indulgence Aesthetics’ Receives FDA Warning Letter

    FDA

    Blaine Labs Issues Voluntary Nationwide Recall of Wound Care Gel

    FDA

    Enforcement Report - Week of April 8, 2026

    FDA

    Ehsan Sadri’s Receives FDA Warning Letter

    FDA

    Cadchem Laboratories Fails EDQM Inspection

    EMA

    Huons Co. is on FDA Import Alert List

    FDA

    Enforcement Report - Week of April 1, 2026

    FDA

    Sun Pharma Fails EDQM Inspection

    EMA

    IDO PHARM is on FDA Import Alert List

    FDA

    Eugia Pharma Fails EDQM Inspection

    EMA

    FDA Issues Form 483 to Revive Rx

    FDA

    Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.